Pulmatrix, Inc. — Form 10-Q
Filed August 13, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 12/100
What the filing says
Pulmatrix filed a standard quarterly report (10-Q) for the period ending June 30, 2026, on August 13, 2026. The filing contains standard XBRL financial data and certification exhibits. No material business transactions, financing events, clinical trial results, partnerships, or operational developments are detailed in the header information provided.
Why this rating
Routine periodic SEC filing with no disclosed material events relative to $25.2M market cap. Standard quarterly disclosure absent business updates.
See more from August 13, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.